Kos Biotechnology Partners Announces Investment in Fathom Therapeutics to Advance Novel, AI-Driven Drug Discovery Platform

The Quick Take
Kos joins Sutter Hill Ventures and other leading investors in backing Fathom Therapeutics's pioneering physics- and AI-powered drug discovery platform NEW YORK and ATHENS, Greece, Nov. 6, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
TENEO LAUNCHES FINANCIAL ADVISORY BUSINESS IN CANADA
TORONTO, Nov. 6, 2026 /PRNewswire/ -- Teneo, the global CEO advisory firm, today announced the expansion of its Financial Advisory business into Canada with…
Business
Starwood Property earnings beat by $0.20, revenue topped estimates
Business
Calumet earnings beat by $1.36, revenue topped estimates
Business
